Mostra el registre parcial de l'element

dc.contributor.authorGarcía-Rueda, Laura
dc.contributor.authorCabanas-Valdés, Rosa
dc.contributor.authorSalgueiro, Carina
dc.contributor.authorRodríguez-Sanz, Jacobo
dc.contributor.authorPérez-Bellmunt, Albert
dc.contributor.authorLópez-de-Celis, Carlos
dc.date.accessioned2023-12-19T15:06:04Z
dc.date.available2023-12-19T15:06:04Z
dc.date.issued2023
dc.identifier.citationGarcía-Rueda, Laura; Cabanas-Valdés, Rosa; Salgueiro, Carina [et al.]. Immediate effects of TECAR therapy on gastrocnemius and quadriceps muscles with spastic hypertonia in chronic stroke survivors: a randomized controlled trial. Biomedicines, 2023, 11(11), 2973. Disponible en: <https://www.mdpi.com/2227-9059/11/11/2973>. Fecha de acceso: 19 dic. 2023. DOI: 10.3390/biomedicines11112973ca
dc.identifier.issn2227-9059ca
dc.identifier.urihttp://hdl.handle.net/20.500.12328/3875
dc.description.abstractBackground: The aim of this study was to assess changes in muscle properties after a single session of capacitive and resistive energetic transfer (TECAR) therapy on spastic gastrocnemius and quadriceps muscles in chronic post-stroke. Methods: A total of 36 chronic stroke survivors with lower limb hypertonia were enrolled in a double-blind randomized controlled trial. The experimental group (n = 18) received a single 30 min session of TECAR therapy in combination with functional massage (FM) on the gastrocnemius and quadriceps muscles. The control group (n = 18) received a sham treatment of TECAR therapy (without electrical stimulation) in combination with real FM. The primary outcome was muscle tone of the lower limb muscles assessed with the Modified Ashworth Scale (MAS). The secondary outcomes were goniometric degrees of the MAS (goniometer), neuromuscular properties of the gastrocnemius/quadriceps (myotonometer), and passive range of motion (inclinometer). All measurements were performed at baseline (T0), immediately after treatment (T1), and at 30 min post-treatment (T2) by a blinded assessor. Results: The MAS score ankle dorsiflexion significantly decreased at T0–T1 (p = 0.046), and the change was maintained at T0–T2 (p = 0.019) in the experimental group. Significant improvements were noted in the passive range of motion for knee flexion (p = 0.012) and ankle dorsiflexion (p = 0.034) at T2. In addition, knee flexion improved at T1 (p = 0.019). Conclusion: A single session of Tecar therapy at the same time with FM on the gastrocnemius and rectus femoris immediately reduces muscle tone and increases the passive range of motion of both ankle and knee in chronic stroke survivors. There were no significant changes in the neuromuscular properties measured with myotonometer.en
dc.format.extent14ca
dc.language.isoengca
dc.publisherMDPIca
dc.relation.ispartofBiomedicinesca
dc.rights© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).en
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.subject.otherTecarteràpiaca
dc.subject.otherIctusca
dc.subject.otherEspasticitatca
dc.subject.otherMassatge funcionalca
dc.subject.otherFuncionalitatca
dc.subject.otherTeràpia de transferència elèctrica capacitiva-resistivaca
dc.subject.otherTecarterapiaes
dc.subject.otherAtaquees
dc.subject.otherEspasticidades
dc.subject.otherMasaje funcionales
dc.subject.otherFuncionalidades
dc.subject.otherTerapia de transferencia eléctrica capacitiva-resistivaes
dc.subject.otherTecar therapyen
dc.subject.otherStrokeen
dc.subject.otherSpasticityen
dc.subject.otherFunctional masajeen
dc.subject.otherFunctionalityen
dc.subject.otherCapacitive– resistive electric transfer therapyen
dc.titleImmediate effects of TECAR therapy on gastrocnemius and quadriceps muscles with spastic hypertonia in chronic stroke survivors: a randomized controlled trialen
dc.typeinfo:eu-repo/semantics/articleca
dc.description.versioninfo:eu-repo/semantics/publishedVersionca
dc.rights.accessLevelinfo:eu-repo/semantics/openAccess
dc.embargo.termscapca
dc.subject.udc61ca
dc.subject.udc616.7ca
dc.identifier.doihttps://dx.doi.org/10.3390/biomedicines11112973ca


Fitxers en aquest element

 

Aquest element apareix en la col·lecció o col·leccions següent(s)

Mostra el registre parcial de l'element

© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Excepte que s'indiqui una altra cosa, la llicència de l'ítem es descriu com https://creativecommons.org/licenses/by/4.0/
Comparteix a TwitterComparteix a LinkedinComparteix a FacebookComparteix a TelegramComparteix a WhatsappImprimeix